Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NLCP Stock Summary
Top 10 Correlated ETFs
NLCP
In the News
NewLake Capital Partners Q4: An 8% Yielding REIT You Should Be Loading Up On (Rating Upgrade)
NewLake Capital Partners reported impressive Q4 earnings, beating estimates on both revenue and FFO. NLCP demonstrated resilience and the ability to navigate challenges, collecting 100% rent during the fourth quarter. The company's healthy balance sheet, low leverage, and growing dividend make it an attractive investment with room for future growth.
Green Real Estate Boom: Must-See Cannabis REITs for Q3 2024
The U.S. cannabis industry is on the brink of something big, drawing attention from investors far and wide. As laws evolve, this market gears up for an impressive leap forward in top marijuana stocks. Enter Cannabis REITs – these are your golden tickets to dip your toes into the cannabis pool without the wild ride of direct stock investments. Also, they lend a helping hand to cannabis companies by providing much-needed real estate capital, crucial for their growth and operations. This week, a handful of top Cannabis REITs are making waves thanks to their solid portfolios and intelligent market moves. They're worth watching for anyone interested in tapping into the industry's potential without getting too caught up in its volatility.
NewLake Capital Partners to Participate in Upcoming April 2024 Investor Conferences
NEW CANAAN, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, announced today that management is scheduled to participate in the following April 2024 investor conferences.
The 2008 REIT Disaster Is Not Likely To Happen Again
REITs are unloved today by the market. Some investors fear that REITs could face another big crash.
High Yield REITs Anyone?
High Yield REITs Anyone?
NewLake Has Stabilized And Remains Attractive
NewLake Capital Partners is a cannabis REIT with a market cap of $340 million, holding 14 cultivation facilities and 17 dispensaries. The company has reported improved performance, with a Q4 revenue of $13 million and 100% rent collections. Catalysts for potential price growth include the continued growth of the cannabis industry and the potential rescheduling of cannabis by the Federal government.
Top 10 Small-Cap Stocks (SA Quant)
The prevailing market sentiment is currently fueled by the allure of "The Magnificent 7" and stocks with high upside potential. Over the last 52 weeks, the S&P 500 is up ~28% compared to the S&P Small-Cap index (~+15%). Small-cap stocks present enticing prospects for growth and value for investors willing to capitalize on calculated risks. The S&P 500 P/E is 25x vs. the S&P Small-Cap at 14.8x.
NewLake Capital Partners, Inc. (NLCP) Q4 2023 Earnings Call Transcript
NewLake Capital Partners, Inc. (OTCQX:NLCP) Q4 2023 Results Conference Call March 11, 2024 11:00 AM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Gordon DuGan - Chairman Anthony Coniglio - President and Chief Executive Officer Lisa Meyer - Chief Financial Officer Jarrett Annenberg - Senior Vice President and Head of Investments Conference Call Participants Pablo Zuanic - Zuanic and Associates Nick Anderson - Roth MKM Operator Good morning. I'll be your conference operator today.
An Important Warning To REIT Investors
The hopes of lower interest rates are fading away. This has caused REITs to sell off again. But we have not lost hope, and you shouldn't either. Here's why.
Cultivating Returns: The Best Cannabis REITs of March 2024
This week, the spotlight shines on top Cannabis Real Estate Investment Trusts (REITs), pivotal players in the burgeoning U.S. cannabis sector. As state-level legalization expands, these REITs offer investors a unique entry point. They finance the growth of dispensaries and cultivation centers. The promise of high yields magnifies this sector's allure, especially in a market carving its niche amidst regulatory challenges. Investors are keenly watching these REITs. Overall, they seek to capitalize on the industry's upward trajectory. Their performance is a barometer for the sector's health and potential.
NLCP Financial details
NLCP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.55 | 1.66 | 2.55 | 2.23 | |
Net income per share | 0 | -0.5 | 0.66 | 1.25 | 1.16 | |
Operating cash flow per share | 0 | 0.35 | 1.57 | 2.11 | 1.89 | |
Free cash flow per share | 0 | 0.35 | 0.68 | -0.47 | 1.21 | |
Cash per share | 0 | 0.92 | 7.47 | 2.57 | 1.22 | |
Book value per share | 0 | 6.35 | 25.13 | 24.11 | 19.11 | |
Tangible book value per share | 0 | 6.64 | 24.41 | 23.29 | 18.53 | |
Share holders equity per share | 0 | 6.35 | 25.13 | 24.11 | 19.11 | |
Interest debt per share | 0 | 0 | 0.14 | 0.19 | 0.16 | |
Market cap | 0 | 637.08M | 487.9M | 281.41M | 338.92M | |
Enterprise value | -21.6M | 617.46M | 364.57M | 239.21M | 315.26M | |
P/E ratio | 0 | -59.72 | 43.43 | 12.81 | 13.79 | |
Price to sales ratio | 0 | 54.62 | 17.3 | 6.28 | 7.16 | |
POCF ratio | 0 | 86.7 | 18.28 | 7.6 | 8.46 | |
PFCF ratio | 0 | 86.7 | 42.3 | -34.16 | 13.24 | |
P/B Ratio | 0 | 4.73 | 1.14 | 0.66 | 0.84 | |
PTB ratio | 0 | 4.73 | 1.14 | 0.66 | 0.84 | |
EV to sales | -78.55 | 52.94 | 12.93 | 5.34 | 6.66 | |
Enterprise value over EBITDA | 25.21 | 203.18 | 18.51 | 6.74 | 8.1 | |
EV to operating cash flow | -59.67 | 84.03 | 13.66 | 6.46 | 7.87 | |
EV to free cash flow | 1.97 | 84.03 | 31.61 | -29.04 | 12.31 | |
Earnings yield | 0 | -0.02 | 0.02 | 0.08 | 0.07 | |
Free cash flow yield | 0 | 0.01 | 0.02 | -0.03 | 0.08 | |
Debt to equity | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 25.21 | -6.46 | -6.26 | -1.19 | -0.61 | |
Current ratio | 120.4 | 6.42 | 10.1 | 2.47 | 1.53 | |
Interest coverage | 0 | 0 | 1.92K | 82.48 | 65.05 | |
Income quality | -0.41 | -0.7 | 2.3 | 1.66 | 1.63 | |
Dividend Yield | 0 | 0.01 | 0.02 | 0.1 | 0.1 | |
Payout ratio | -0.11 | -0.49 | 1.05 | 1.33 | 1.34 | |
Sales general and administrative to revenue | 8.01 | 0.75 | 0.3 | 0.21 | 0.16 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -31.33 | 0 | -0.57 | -1.22 | -0.36 | |
Capex to revenue | -41.25 | 0 | -0.54 | -1.01 | -0.31 | |
Capex to depreciation | -333.62 | 0 | -1.87 | -3.53 | -1.01 | |
Stock based compensation to revenue | 0.02 | 0.4 | 0.07 | 0.03 | 0.03 | |
Graham number | 0 | 8.47 | 19.32 | 26.05 | 22.35 | |
ROIC | -0.02 | 0 | 0.03 | 0.05 | 0.06 | |
Return on tangible assets | -0.02 | -0.07 | 0.03 | 0.05 | 0.06 | |
Graham Net | 0 | 0.78 | 7.53 | 1.46 | 0.38 | |
Working capital | 66.35M | 17.07M | 142.31M | 29.87M | 10.57M | |
Tangible asset value | 53.25M | 141.03M | 415.33M | 409.17M | 392.18M | |
Net current asset value | 64.32M | 17.07M | 136.41M | 26.88M | 9.34M | |
Invested capital | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Average receivables | 0 | 0 | 15M | 17.5M | 4.92M | |
Average payables | 0 | 0 | 702K | 1.53M | 1.39M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 388.28 | 40.74 | 37.29 | |
Days payables outstanding | 0 | 0 | 3.56K | 10.09K | 27.32 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0.94 | 8.96 | 9.79 | |
Payables turnover | 0 | 0 | 0.1 | 0.04 | 13.36 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.02 | -0.08 | 0.03 | 0.05 | 0.06 | |
Capex per share | 0 | 0 | -0.89 | -2.58 | -0.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.57 | 0.53 | 0.53 | 0.54 | 0.63 | |
Net income per share | 0.31 | 0.27 | 0.27 | 0.28 | 0.34 | |
Operating cash flow per share | 0.63 | 0.38 | 0.47 | 0.44 | 0.6 | |
Free cash flow per share | 0.55 | 0.32 | 0.39 | 0.32 | 0.17 | |
Cash per share | 2.11 | 1.94 | 1.9 | 1.47 | 1.25 | |
Book value per share | 19.77 | 19.64 | 19.55 | 19.25 | 19.55 | |
Tangible book value per share | 19.1 | 18.99 | 18.92 | 18.64 | 18.95 | |
Share holders equity per share | 19.77 | 19.64 | 19.55 | 19.25 | 19.55 | |
Interest debt per share | 0.14 | 0.1 | 0.1 | 0.1 | 0.15 | |
Market cap | 343.19M | 264.58M | 294.9M | 288.74M | 331.27M | |
Enterprise value | 300.98M | 225.07M | 256.22M | 259.67M | 307.61M | |
P/E ratio | 12.82 | 11.27 | 12.72 | 12.12 | 11.9 | |
Price to sales ratio | 28.19 | 23.18 | 25.92 | 25.13 | 25.44 | |
POCF ratio | 25.45 | 32.12 | 29.56 | 30.75 | 26.63 | |
PFCF ratio | 29.19 | 38.71 | 35.18 | 42.61 | 91.69 | |
P/B Ratio | 0.81 | 0.63 | 0.71 | 0.71 | 0.82 | |
PTB ratio | 0.81 | 0.63 | 0.71 | 0.71 | 0.82 | |
EV to sales | 24.72 | 19.72 | 22.52 | 22.6 | 23.62 | |
Enterprise value over EBITDA | 28.33 | 23.39 | 26.79 | 26.69 | 27.3 | |
EV to operating cash flow | 22.32 | 27.32 | 25.68 | 27.66 | 24.73 | |
EV to free cash flow | 25.6 | 32.93 | 30.56 | 38.32 | 85.14 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | |
Debt to equity | 0.01 | 0 | 0 | 0 | 0.01 | |
Debt to assets | 0.01 | 0 | 0 | 0 | 0.01 | |
Net debt to EBITDA | -3.97 | -4.11 | -4.04 | -2.99 | -2.1 | |
Current ratio | 2.47 | 2.57 | 2.5 | 2.06 | 1.53 | |
Interest coverage | 65.13 | 63.5 | 59.66 | 62.98 | 81.05 | |
Income quality | 1.98 | 1.38 | 1.69 | 1.55 | 1.79 | |
Dividend Yield | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | |
Payout ratio | 1.18 | 1.43 | 1.44 | 1.4 | 1.16 | |
Sales general and administrative to revenue | 0.13 | 0.18 | 0.18 | 0.17 | 0.12 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.13 | -0.17 | -0.16 | -0.28 | -0.71 | |
Capex to revenue | -0.14 | -0.12 | -0.14 | -0.23 | -0.68 | |
Capex to depreciation | -0.47 | -0.39 | -0.45 | -0.73 | -2.47 | |
Stock based compensation to revenue | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
Graham number | 11.79 | 11 | 10.92 | 11.03 | 12.17 | |
ROIC | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Graham Net | 1.2 | 1.16 | 1.13 | 0.71 | 0.39 | |
Working capital | 29.87M | 29.57M | 28.57M | 19.54M | 10.57M | |
Tangible asset value | 409.17M | 406.84M | 404.4M | 395.2M | 392.18M | |
Net current asset value | 26.88M | 28.1M | 27.36M | 18.34M | 9.34M | |
Invested capital | 0.01 | 0 | 0 | 0 | 0.01 | |
Average receivables | 5M | 5M | 5M | 5M | 4.92M | |
Average payables | 1.81M | 1.47M | 1.35M | 1.21M | 1.06M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 36.96 | 39.42 | 39.56 | 39.16 | 33.41 | |
Days payables outstanding | 1.22K | 32.2 | 35.92 | 25.22 | 28.18 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.44 | 2.28 | 2.28 | 2.3 | 2.69 | |
Payables turnover | 0.07 | 2.8 | 2.51 | 3.57 | 3.19 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Capex per share | -0.08 | -0.07 | -0.07 | -0.12 | -0.43 |
NLCP Frequently Asked Questions
What is NewLake Capital Partners, Inc. stock symbol ?
NewLake Capital Partners, Inc. is a US stock , located in New canaan of Ct and trading under the symbol NLCP
What is NewLake Capital Partners, Inc. stock quote today ?
NewLake Capital Partners, Inc. stock price is $18.97 today.
Is NewLake Capital Partners, Inc. stock public?
Yes, NewLake Capital Partners, Inc. is a publicly traded company.